专题:Protein Tyrosine Phosphatases

This cluster of papers explores the role of protein tyrosine phosphatases, particularly PTPN11 and SHP2, in various human health and disease conditions such as Noonan syndrome, cancer, insulin sensitivity, and MAP kinase signaling. It also delves into the redox regulation of protein tyrosine phosphatases and their implications in cell signaling pathways.
最新文献
The impact of K-Ras Gly12 mutants on homeostasis and tumorigenesis in the colonic epithelium

article Full Text OpenAlex

Targeting TROP‑2 in treatment‑resistant non‑small cell lung cancer harboring the KRAS G12C mutation and TROP‑2 upregulation: A case report

article Full Text OpenAlex

Role of dual specificity phosphatase 1 in influencing inflammatory pathways in macrophages modulated by Borrelia burgdorferi lipoproteins

article Full Text OpenAlex

Harnessing viral strategies to reverse cognitive dysfunction through the integrated stress response

article Full Text OpenAlex

The role and significance of the PI3K/Akt-mTOR signaling pathway in infectious diseases

article Full Text OpenAlex

JI-CJ001 Enhances Paclitaxel Sensitivity in Gastric Cancer Cell Lines through Inhibition of HER2/mTOR Signaling and Induction of Autophagy

article Full Text OpenAlex

MAPK Phosphatase-3 Mediates Chronic Endoplasmic Reticulum Stress Promoting Hepatic Gluconeogenesis

article Full Text OpenAlex

DUSP4 in Colorectal Cancer: A Mini Review of Expressions, Functions, Mechanisms

article Full Text OpenAlex

DUSP12 promotes cell cycle progression and protects cells from ZNF622 mediated apoptosis

article Full Text OpenAlex

Human MKP-3 isoforms display differential structural and functional profiles

article Full Text OpenAlex

近5年高被引文献
Translational and Therapeutic Evaluation of RAS-GTP Inhibition by RMC-6236 in RAS-Driven Cancers

article Full Text OpenAlex 256 FWCI56.5356

Cancer‐associated fibroblast‐derived secreted phosphoprotein 1 contributes to resistance of hepatocellular carcinoma to sorafenib and lenvatinib

article Full Text OpenAlex 173 FWCI25.7847

The RASopathies: from pathogenetics to therapeutics

review Full Text OpenAlex 167 FWCI13.8662

The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity

article Full Text OpenAlex 162 FWCI24.1322

KRASG12C-independent feedback activation of wild-type RAS constrains KRASG12C inhibitor efficacy

article Full Text OpenAlex 147 FWCI11.4568

Targeting galectin-3 in inflammatory and fibrotic diseases

review Full Text OpenAlex 140 FWCI22.3158

Discovery, Preclinical Characterization, and Early Clinical Activity of JDQ443, a Structurally Novel, Potent, and Selective Covalent Oral Inhibitor of KRASG12C

article Full Text OpenAlex 134 FWCI10.7463

Human Protein Tyrosine Phosphatase 1B (PTP1B): From Structure to Clinical Inhibitor Perspectives

review Full Text OpenAlex 129 FWCI10.0532

Increased hyaluronan by naked mole-rat Has2 improves healthspan in mice

article Full Text OpenAlex 124 FWCI10.8812

Targeting protein phosphatases in cancer immunotherapy and autoimmune disorders

review Full Text OpenAlex 117 FWCI17.7494